143 related articles for article (PubMed ID: 24948406)
1. When is enough…enough? Developing consensus of definition of failure of immune tolerance induction in patients with haemophilia and inhibitors.
Barnes C; Brown SA; Curtin J; Dunkley S
Haemophilia; 2014 Jul; 20(4):e275-9. PubMed ID: 24948406
[TBL] [Abstract][Full Text] [Related]
2. Immune tolerance induction using a factor VIII/von Willebrand factor concentrate (BIOSTATE), with or without immunosuppression, in Australian paediatric severe haemophilia A patients with high titre inhibitors: a multicentre, retrospective study.
Robertson JD; Higgins P; Price J; Dunkley S; Barrese G; Curtin J
Thromb Res; 2014 Nov; 134(5):1046-51. PubMed ID: 25267706
[TBL] [Abstract][Full Text] [Related]
3. Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units.
Ter Avest PC; Fischer K; Gouw SC; Van Dijk K; Mauser-Bunschoten EP
Haemophilia; 2010 May; 16(102):71-9. PubMed ID: 20536988
[TBL] [Abstract][Full Text] [Related]
4. Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.
Gringeri A; Musso R; Mazzucconi MG; Piseddu G; Schiavoni M; Pignoloni P; Mannucci PM;
Haemophilia; 2007 Jul; 13(4):373-9. PubMed ID: 17610550
[TBL] [Abstract][Full Text] [Related]
5. The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.
Greninger DA; Saint-Remy JM; Jacquemin M; Benhida A; DiMichele DM
Haemophilia; 2008 Mar; 14(2):295-302. PubMed ID: 18081826
[TBL] [Abstract][Full Text] [Related]
6. Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate.
Oldenburg J; Jiménez-Yuste V; Peiró-Jordán R; Aledort LM; Santagostino E
Haemophilia; 2014 Jan; 20(1):83-91. PubMed ID: 24354480
[TBL] [Abstract][Full Text] [Related]
7. Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study).
Rocino A; Cortesi PA; Scalone L; Mantovani LG; Crea R; Gringeri A; ;
Haemophilia; 2016 Jan; 22(1):96-102. PubMed ID: 26278414
[TBL] [Abstract][Full Text] [Related]
8. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.
Unuvar A; Kavakli K; Baytan B; Kazanci E; Sayli T; Oren H; Celkan T; Gursel T
Haemophilia; 2008 Mar; 14(2):315-22. PubMed ID: 18081830
[TBL] [Abstract][Full Text] [Related]
9. Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice.
Benson G; Auerswald G; Elezović I; Lambert T; Ljung R; Morfini M; Remor E; Salek SZ
Eur J Haematol; 2012 May; 88(5):371-9. PubMed ID: 22260405
[TBL] [Abstract][Full Text] [Related]
10. Immune tolerance induction in haemophilia A patients with inhibitors by treatment with recombinant factor VIII: a retrospective non-interventional study.
Rivard GE; Rothschild C; Toll T; Achilles K
Haemophilia; 2013 May; 19(3):449-55. PubMed ID: 23510123
[TBL] [Abstract][Full Text] [Related]
11. Current view and outcome of ITI therapy - A change over time?
Holstein K; Batorova A; Carvalho M; Fijnvandraat K; Holme P; Kavakli K; Lambert T; Rocino A; Jiménez-Yuste V; Astermark J;
Thromb Res; 2016 Dec; 148():38-44. PubMed ID: 27770665
[TBL] [Abstract][Full Text] [Related]
12. Immune tolerance: critical issues of factor dose, purity and treatment complications.
DiMichele DM
Haemophilia; 2006 Dec; 12 Suppl 6():81-5; discussion 85-6. PubMed ID: 17123399
[TBL] [Abstract][Full Text] [Related]
13. A review of immune tolerance induction with Haemate P in haemophilia A.
Escuriola Ettingshausen C; Kreuz W
Haemophilia; 2014 May; 20(3):333-9. PubMed ID: 24165472
[TBL] [Abstract][Full Text] [Related]
14. Late immune tolerance induction in haemophilia A patients.
Meeks SL; Chapman RL; Kempton C; Dunn AL
Haemophilia; 2013 May; 19(3):445-8. PubMed ID: 23294063
[TBL] [Abstract][Full Text] [Related]
15. The Japanese Immune Tolerance Induction (J-ITI) study in haemophilia patients with inhibitor: Outcomes and successful predictors of ITI treatment.
Nogami K; Taki M; Matsushita T; Ohga S; Oka T; Horikoshi Y; Amano K; Shima M
Haemophilia; 2018 Sep; 24(5):e328-e337. PubMed ID: 29902361
[TBL] [Abstract][Full Text] [Related]
16. Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors.
Astermark J; Morado M; Rocino A; van den Berg HM; von Depka M; Gringeri A; Mantovani L; Garrido RP; Schiavoni M; Villar A; Windyga J;
Haemophilia; 2006 Jul; 12(4):363-71. PubMed ID: 16834735
[TBL] [Abstract][Full Text] [Related]
17. Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors-A retrospective analysis.
Carcao M; Shapiro A; Staber JM; Hwang N; Druzgal C; Lieuw K; Belletrutti M; Thornburg CD; Ahuja SP; Morales-Arias J; Dumont J; Miyasato G; Tsao E; Jain N; Pipe SW
Haemophilia; 2018 Mar; 24(2):245-252. PubMed ID: 29436077
[TBL] [Abstract][Full Text] [Related]
18. Use of Haemate(®) P as immune tolerance induction in patients with severe haemophilia A who failed previous induction attempts: a multicentre observational study.
Rothschild C; D'Oiron R; Borel-Derlon A; Gruel Y; Navarro R; Negrier C
Haemophilia; 2013 Mar; 19(2):281-6. PubMed ID: 23038998
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous disappearance of high titre factor VIII inhibitor 15 years after unsuccessful ITI.
Thom K; Male C; Falger J; Pabinger I
Hamostaseologie; 2009 May; 29(2):149-50. PubMed ID: 19404512
[TBL] [Abstract][Full Text] [Related]
20. Management of patients with long-term inhibitors: is immune tolerance an underestimated life-long solution?
Di Minno G; Coppola A
Haemophilia; 2013 Jan; 19 Suppl 1():18-23. PubMed ID: 23278996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]